About
OneBiosciences develops AI-powered single-cell profiling technology to provide clinical-grade, high-resolution cellular analysis from standard biopsy samples, aimed at improving clinical decision-making and accelerating therapeutic development.
Explore OneBiosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.